Glazer Capital, LLC 13D and 13G filings for Checkpoint Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-03-17 4:08 pm Purchase | 2025-03-10 | 13G | Checkpoint Therapeutics, Inc. CKPT | Glazer Capital, LLC | 3,087,052 6.410% | 3,087,052 (New Position) | Filing |